Mounjaro 7.5 mg
Tirzepatide
Mounjaro 7.5mg aids weight loss and type 2 diabetes control by improving insulin sensitivity, reducing appetite, and helping regulate blood sugar levels effectively.
- Strengths 7.5
- Form Injection
- Packaging Size 2.4ml x 4
- Packaging Type Box
- Manufacturer Eli Lilly
Description of Mounjaro 7.5 mg
Mounjaro 7.5mg is a prescription injectable medication used for managing type 2 diabetes and promoting weight loss. It contains Tirzepatide, a dual GIP and GLP-1 receptor agonist that improves blood sugar control while curbing appetite and slowing gastric emptying. Mounjaro 7.5mg helps reduce food intake and supports long-term weight management goals. It’s administered once a week under the skin and is most effective when combined with a balanced diet and regular physical activity. Suitable for adults only, Mounjaro must be used under medical supervision to ensure safe and optimal results in diabetes and obesity management.
Ingredients of Mounjaro 7.5 mg
- Tirzepatide (7.5mg)
- Sodium chloride
- Buffering agents
- Water for injection
Usage of Mounjaro 7.5 mg
- Subcutaneous injection once weekly.
- Dosage adjustment should be done only by a healthcare professional.
- Inject in the abdomen, thigh, or upper arm.
- Can be taken with or without food.
Precautions for Mounjaro 7.5 mg
- Not for use in type 1 diabetes or diabetic ketoacidosis.
- Avoid if you have a history of thyroid cancer or pancreatitis.
- May cause nausea, vomiting, or low blood sugar.
- Not recommended during pregnancy or breastfeeding unless advised.
- Regular blood glucose monitoring is important during treatment.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
